Document is current
Any future updates will be listed below
-
Authors
Banerjee, Rahul https://orcid.org/0000-0003-3781-5441
Wang, Bo
Anderson, Larry D. Jr https://orcid.org/0000-0002-6531-9595
McCaughan, Georgia
Mehra, Nikita
Cowan, Andrew J. https://orcid.org/0000-0002-1880-7094
Rajkumar, S. Vincent https://orcid.org/0000-0002-5862-1833
Kaur, Gurbakhash
- License Information
-
More Information
Article History
Received: 24 August 2023
Revised: 16 October 2023
Accepted: 25 October 2023
First Online: 6 November 2023
Competing interests
: RB: Consulting: BMS, Caribou Biosciences, Genentech, Janssen, Pfizer, Sanofi, SparkCures; Research: Pack Health. GK: Consulting: BMS, Arcellx, Sanofi, Janssen, Pfizer, Kedrion; Research: BMS, Janssen, Abbvie. BW: Consulting: Sanofi, EMD Sorono, AstraZeneca, Janssen, BMS. LDA: Consulting: Janssen, BMS/Celgene, Amgen, GSK, AbbVie, Beigene, Cellectar, Sanofi, Prothena. GM: Consulting: BMS, Janssen. NM: No interests to disclose. AJC: Consulting: BMS, Adaptive; Research: Adaptive Biotechnologies, Harpoon, Nektar, BMS, Janssen, Sanofi, AbbVie. SVR: No interests to disclose.
